Related Experiment Video
Updated: Feb 24, 2026
04:50
Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
1.2K
Biomarkers in Rheumatoid Arthritis
Fabiola Atzeni1, Rossella Talotta2, Ignazio F Masala3
1IRCCS Galeazzi Orthopedic Institute, Milan, Italy.
The Israel Medical Association Journal : IMAJ
|August 22, 2017
Summary
Biomarkers are crucial for rheumatoid arthritis (RA) management, aiding early detection, diagnosis, and personalized treatment. Utilizing predictive biomarkers improves patient stratification and outcomes in the era of biologic therapies.
Area of Science:
- Rheumatology
- Immunology
- Biomarker Discovery
Background:
- Biomarkers are essential for all stages of rheumatoid arthritis (RA) management.
- They aid in predicting disease development, improving diagnosis, and guiding therapeutic choices.
- Biomarkers help monitor disease activity and treatment responses.
Purpose of the Study:
- To highlight the importance of biomarkers in rheumatoid arthritis.
- To discuss the role of biomarkers in patient stratification and personalized medicine.
- To emphasize the impact of biomarkers on treatment selection and outcomes.
Main Methods:
- Review of current literature on rheumatoid arthritis biomarkers.
- Analysis of established and emerging biomarkers for RA.
- Discussion of diagnostic, prognostic, and predictive biomarker applications.
Main Results:
- Biomarkers like rheumatoid factor and anti-citrullinated protein antibodies identify at-risk individuals and predict disease severity.
- Erythrocyte sedimentation rate and C-reactive protein indicate disease activity.
- Predictive biomarkers assess treatment response likelihood, especially for biologic drugs.
Conclusions:
- Biomarkers are vital for accurate rheumatoid arthritis diagnosis and prognosis.
- Personalized treatment strategies based on biomarkers improve patient care.
- The use of biomarkers facilitates targeted therapy, enhancing efficacy and reducing costs.
Related Concept Videos
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
752
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
752
01:11Genome-wide Association Studies-GWAS
15.9K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
15.9K
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
633
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
633
01:20The JAK-STAT Signaling Pathway
13.3K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
13.3K